Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

NCT06629389 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Cannabidiol 100 mg/ml
DRUG: cannabidiol 300 mg/ml
DRUG: Cannabidiol 400 mg/ml
DRUG: Placebo

Sponsor

Laboratorio Elea Phoenix S.A.